Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jilei Jia

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Reproductive Toxicology (Elmsford, N.Y.)|March 6, 2025
Developmental and reproductive toxicity (DART) study of a novel SARS-CoV-2 tetravalent recombinant protein vaccine (SCTV01E) in ratsXiao Zhang, Jilei Jia, Gaojian Chen, et al.
Vaccines|March 30, 2023
A Polysaccharide-RBD-Fc-Conjugated COVID-19 Vaccine, SCTV01A, Showed High Immunogenicity and Low Toxicity in Animal ModelsChunyun Sun, Desheng Kong, Erhong Guo, et al.
Pharmaceutical Research|July 26, 2022
Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus MonkeysJilei Jia, Zhaojuan Yin, Xiao Zhang, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal AntibodyYunqi Yao, Xiaoning Yang, Jing Li, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Reproductive Toxicology (Elmsford, N.Y.)|March 6, 2025
Developmental and reproductive toxicity (DART) study of a novel SARS-CoV-2 tetravalent recombinant protein vaccine (SCTV01E) in ratsXiao Zhang, Jilei Jia, Gaojian Chen, et al.
Vaccines|March 30, 2023
A Polysaccharide-RBD-Fc-Conjugated COVID-19 Vaccine, SCTV01A, Showed High Immunogenicity and Low Toxicity in Animal ModelsChunyun Sun, Desheng Kong, Erhong Guo, et al.
Pharmaceutical Research|July 26, 2022
Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus MonkeysJilei Jia, Zhaojuan Yin, Xiao Zhang, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal AntibodyYunqi Yao, Xiaoning Yang, Jing Li, et al.
Pageof 2